Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kan Jang Oral Solution vs placebo for common cold
2009-012640-17Phase 4Terminated
- Sponsor
- Swedish Herbal Institute
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in nasopharyngitis and upper respiratory infection (URI) comparing Kan Jang Oral Solution with Placebo (2 arms). Primary endpoint: Duration of acute disease manifestations. Started Aug 2009; status: terminated.
02
Drugs
Kan Jang
03
Conditions
nasopharyngitisupper respiratory infection (URI)
Beyond the preview
Go deeper on 2009-012640-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012640-17.